Sort
15,842 grants matching “pancreatic cancer”
Quantitative diagnosis of TB/HIV co-infection using pathogen-specific exosomes in blood
$78,208Jia Fan · Arizona State University-Tempe Campus · R03 · FY2018 · AI
Salicylic acid-based small-molecule Stat3 inhibitors for anticancer therapy
$78,134James K Turkson · University Of Hawaii At Manoa · R01 · FY2014 · CA
The role of progenitor cells in pancreatic acinar renewal and pre-malignant progression
$78,065Ravikanth Maddipati · Ut Southwestern Medical Center · K08 · FY2019 · DK
Elucidating the relevance of BARD1-PLK1 interaction in PDAC and response to therapy
$78,000Aditi Jain · Thomas Jefferson University · R03 · FY2023 · CA
Elucidating the relevance of BARD1-PLK1 interaction in PDAC and response to therapy
$78,000Aditi Jain · Thomas Jefferson University · R03 · FY2024 · CA
Targeting DCLK1 kinase activity in pancreatic cancer
$77,826Courtney Wayne Houchen · University Of Oklahoma Hlth Sciences Ctr · R21 · FY2016 · CA
Role of MFG-E8 in Tumor Biology and Immunophysiology
$77,784Mark Udey · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
PhScN as a Potent Agent for Use with Radiation in Pancreatic Cancer
$77,750Donna Lucy Livant · University Of Michigan At Ann Arbor · R03 · FY2012 · CA
PhScN as a Potent Agent for Use with Radiation in Pancreatic Cancer
$77,750Donna Lucy Livant · University Of Michigan At Ann Arbor · R03 · FY2013 · CA
Role of MFG-E8 in Tumor Biology and Immunophysiology
$77,717Mark Udey · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
CLINICAL RESEARCH OFFICE (SHARED RESOURCE)
$77,675David Hsiang · University Of California-Irvine · P30 · FY2011 · CA
Improving Pancreas RT Plans using Respiration-driven Anatomic Deformation
$77,661Wensha Yang · Cedars-Sinai Medical Center · R03 · FY2014 · CA
Cancer Therapeutics Research Program
$77,593Ravi K Amaravadi · University Of Pennsylvania · P30 · FY2019 · CA
Developmental Research Program
$77,587Donald J Buchsbaum · University Of Alabama At Birmingham · P50 · FY2013 · CA
Medical History, Medications, and Pancreatic Cancer Risk
$77,550Group Health Cooperative · R03 · FY2003 · CA
OGF & Gemcitabine: A Novel Treatment for Pancreatic Cancer: Phase I Study
$77,550Jill P Smith · Pennsylvania State Univ Hershey Med Ctr · R03 · FY2009 · CA
OPPC targeting to improve pancreatic cancer treatment
$77,550George C Prendergast · Lankenau Institute For Medical Research · R03 · FY2013 · CA
Cancer Therapeutics Research Program
$77,523Ravi K Amaravadi · University Of Pennsylvania · P30 · FY2020 · CA
Enhancing intratumoral T cell infiltration by deliver of shCXCL5 in a Plectin targeted AAV to improve checkpoint blockade efficacy
$77,500Michael Nathan Vansaun · University Of Kansas Medical Center · R03 · FY2025 · CA
Molecular Mechanisms of Adverse Metabolic Events by Asparaginase.
$77,500Tracy G. Anthony · Rutgers, The State Univ Of N.J. · R01 · FY2014 · HD
The Effect of Alcohol on NADPH oxidase structure in pancreatic stellate cells
$77,500Kym Francis Faull · University Of California Los Angeles · R03 · FY2007 · AA
The Effect of Alcohol on NADPH oxidase structure in pancreatic stellate cells
$77,500Kym Francis Faull · University Of California Los Angeles · R03 · FY2008 · AA
Pancreatic Tumor Progression in the Absence of ADAM-mediated alpha-secretase Acti
$77,500Howard C Crawford · State University New York Stony Brook · R03 · FY2008 · CA
Enhancing intratumoral T cell infiltration by deliver of shCXCL5 in a Plectin targeted AAV to improve checkpoint blockade efficacy
$77,500Michael Nathan Vansaun · University Of Kansas Medical Center · R03 · FY2024 · CA
Pancreatic Tumor Progression in the Absence of ADAM-mediated alpha-secretase Acti
$77,500Howard C Crawford · State University New York Stony Brook · R03 · FY2007 · CA